Winthrop P. Rockefeller Cancer Institute


February 23, 2024

UAMS Myeloma Patient Grateful for ‘Life Changing’ Treatment

Nathan Tidwell

Jim and Laurie Schepers.

Jim Schepers remembers getting a call he didn’t want in April 2020. The call was from Frits van Rhee, M.D., Ph.D., clinical director of the Myeloma Center at the University of Arkansas for Medical Sciences (UAMS) and Schepers’ physician — cancer had returned. “When we found out the cancer was back, Dr. van Rhee called…


February 9, 2024

NIH Funds Study of UAMS Nurses’ Influence on Heart Failure Patient Outcomes

David Robinson

Tremaine Williams, Ed.D., at his desk at UAMS.

A University of Arkansas for Medical Sciences (UAMS) research team led by Tremaine Williams, Ed.D., has received a National Institutes of Health (NIH) grant to better understand how nurses influence outcomes of heart failure patients. About 6.2 million people in the United States have heart failure. The two-year, $406,897 R21 grant from the NIH National…


February 1, 2024

UAMS Winthrop P. Rockefeller Cancer Institute Achieves $30 Million Fundraising Goal for NCI Designation

Andrew Vogler

NCI Designation fundraising goal press conference

LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) met its $30 million fundraising goal for the Winthrop P. Rockefeller Cancer Institute’s campaign to achieve National Cancer Institute (NCI) Designation. The fundraising milestone was achieved with a $5 million gift from the Chris Fowler family of Jonesboro. In total, 8,700 philanthropic gifts have…


January 19, 2024

Arkansan Sees Advanced Cancer Disappear with Experimental Drug Offered at UAMS Winthrop P. Rockefeller Cancer Institute

Marty Trieschmann

Dr. Michael Birrer speaks with a patient during a clinic visit

A Little Rock man with resistant kidney cancer who underwent experimental immunotherapy in Phase 1 Clinical Trials at the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute has experienced a complete remission.


January 18, 2024

UAMS Winthrop P. Rockefeller Cancer Institute to Hold Health Fair in Huntsville on Feb. 9

Marty Trieschmann

a doctor and patient interacting at a health fair

The University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute will host a free public health fair at the Madison County Public Library in Huntsville on Feb. 9. The event will run from 10 a.m. to 1 p.m. at the library, located at 827 N. College St. Patient navigators from the UAMS…


December 15, 2023

Nurse Passionate About Success, Impact of UAMS Myeloma Center

Kev' Moye

Heather Brown, APRN

Heather Brown, APRN, a nurse practitioner for the University of Arkansas for Medical Sciences (UAMS) Winthrop P. Rockefeller Cancer Institute’s Myeloma Center, appreciates the opportunity to serve the patients. A 2001 graduate of the UAMS College of Nursing, Brown quickly learned about myeloma as the center opened shortly after she was hired by the institute….


Intake Team Serves as Source of Comfort for Myeloma Center Patients

Chris Carmody

(Left to right) Christy Bunting, Amy Ford, Melissa Thomas, April Thomas.

For new patients of the UAMS Myeloma Center, the intake process provides their first impression of the support they’ll receive during a difficult period of their lives. “It’s important that we help them get established and make sure they’re comfortable coming here,” said Christy Bunting, an intake coordinator in the Myeloma Center. “We want them…


UAMS Myeloma Researcher Sees‘ Impressive’ Results in Clinical Trials of Bispecific Antibody Treatments

David Robinson

Carolina Schinke, M.D.

Many patients at the UAMS Myeloma Center have relapsed refractory myeloma, meaning they have nearly run out of effective treatment options. Fortunately, the center has talented clinical researchers like Carolina Schinke, M.D., with access to the latest medications, including promising study drugs. Schinke is leading a clinical trial at UAMS of a promising new bispecific…


December 14, 2023

UAMS Researcher Takes Aim at Drug-Resistant Myeloma

David Robinson

Fenghuang (Frank) Zhan, M.D., Ph.D.

  UAMS Myeloma Center researcher Fenghuang (Frank) Zhan, M.D., Ph.D., has spent his career in search of clues to help fight drug-resistant myeloma. His findings recently led him to establish a translational research project to beat drug-resistant myeloma for his 11-member myeloma research team, based at the UAMS Winthrop P. Rockefeller Cancer Institute. While the…


New Immune Therapies Provide Promising Advances in Myeloma Care

News Staff

Frits van Rhee, MD, Ph.D.

By Frits van Rhee, MD, Ph.D. Since the late 1990s, 16 drugs have been approved for the treatment of multiple myeloma, including proteasome inhibitors, such as bortezomib and carfilzomib, and the immunomodulatory class of agents comprising thalidomide, lenalidomide and pomalidomide. Immune therapy with the antibody daratumumab was first approved in 2015. These three classes of…



Next page